Th۱ and Th۲ Cytokine Gene Expression in the Peripheral Blood of Breast Cancer Patients Compared to Controls

Publish Year: 1393
نوع سند: مقاله ژورنالی
زبان: English
View: 54

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_MISJ-5-3_002

تاریخ نمایه سازی: 25 آبان 1402

Abstract:

Background: Cytokines produced by different subsets of T cells are the key mediators to adjust the quality of immune responses. Despite evidence of induction of an immune reaction against tumors such as breast cancer, not all responses are protective. In this study we attempt to evaluate the expression profile of several cytokines from the T helper ۱ and ۲ subsets in blood cells from patients with breast cancer.Methods:We recruited ۱۰۰ recently diagnosed patients with confirmed pathological reports. Peripheral blood samples were taken and the expression of the transcripts for IL-۲, IL-۱۲A, IL-۱۲B, IFN-γ, IL-۴, IL-۱۰, IL-۱۳ and IL-۱۳Rα۲ were measured by quantitative real time PCR. We correlated the results to clinical findings and compared the results to those from ۶۴ healthy individuals.Results: Among the studied cytokines, we observed a significant increase in the expression of T helper ۱ pro-inflammatory cytokines IL-۱۲B, IL-۲ and IFN-γ compared to healthy controls. Elevated expression of those cytokines was associated with high stage and/or high grade tumors but there was no association with other clinical determinants. Simultaneously, blood cells showed high expression of IL-۱۰, but not the other studied T helper ۲ cytokines.Conclusion: The mixed and complex cytokine profile of T helper ۱ and ۲ immunity in blood cells may show an immunological imbalance which makes the overall system favor cancer. This may be a potential target for immunotherapy approaches, however more comprehensive results are needed.

Authors

Ahmad Hosseini Tashnizi

Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Mojtaba Habibagahi

Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Jafar Majidi

Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

Mahboobeh Razmkhah

Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Abdolrasoul Talei

Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Abbas Ghaderi

Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Mansooreh Jaberipour

Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran